ACTSI Newsletter
|
Trouble viewing this email? Click here
to view on the web.
| |
| |  | 
ACTSI Weekly eRoundup
February 26, 2016
|
| |
| | | | | The Atlanta Clinical & Translational Science Institute’s (ACTSI) Community Engagement Research Program (CERP) is a core component of a collaborative effort between Emory University, Morehouse School of Medicine, and Georgia Institute of Technology. ACTSI’s CERP aims to improve the way biomedical research is conducted and disseminated throughout the city and across the country, building community capacity to conduct health research that ... | | | | Read More | | |
|
| |
| | | | | The Healthcare Innovation Symposium XVI series, with hosts Emory-Georgia Tech Health Innovation Program and ACTSI presents Eugene Washington, MD, MPH, MSc, Chancellor for Health Affairs, Duke University, President and CEO, Duke University Health System. ... | | | | Read More | | | | |
|
| |
| | | | Designed to increase the number of novel and repurposed treatments tested in humans for Alzheimer's disease, related dementias, and cognitive aging. It funds biomarker-based, proof-of-concept pilot clinical trials for Alzheimer's, as well as Phase 1 safety testing and IND-enabling studies to accelerate new drugs into trials. | | | | Read More | | |
| |
| | | | NCATS has several open Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program funding opportunities designed to help advance and commercialize translational research technologies. NCATS encourages applications in these research areas of interest: drug discovery and development, diagnostics and devices, bioinformatics and information technology and clinical research. | | | | Read More | | |
| |
| | | | Supports research with novel and innovative hypotheses, performed in human subjects, or research approaches to accelerate the transition of scientific discoveries into clinical application. | | | | Read More | | |
| |
| | | | In 2014, the U.S. Government released the National Strategy for Combating Antimicrobial Resistant Bacteria. A component of the strategy is to establish a Biopharmaceutical Accelerator for Combating Antibiotic-Resistant Bacteria [Accelerator] to fund Research and Development (R&D) activities to help progress candidate products from the proof-of-concept stage through pre-clinical development. | | | | Read More | | |
| |
| | | | Supports early investigators as they establish independence as diabetes researchers. | | | | Read More | | |
| |
| | | | The goal of this FOA is to move commercially-viable vaccines and products for treatment and prevention of diseases relevant to NIAID's mission from NIAID intramural research laboratories into the marketplace. This FOA solicits Small Business Innovation Research (SBIR) grant applications from Small Business Concerns (SBCs) for projects that incorporate the appropriate research expertise (company, NIAID Intramural or external collaborators/consortiums) to further develop and commercialize such inventions. | | | | Read More | | |
| |
| | | | A total of $140,000 worth of BD Biosciences research reagents are awarded annually to 14 scientists. Through the grant program, BD Biosciences works to support innovation in research and development, helping to define the next generation of scientific breakthroughs. | | | | Read More | | |
| |
| | | | This FOA solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any federal agency. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and/or in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. | | | | Read More | | |
| |
| | | | The COD Fellowship Committee is now accepting applications for the 2016-2017 COD Fellowship Program, which will run from September 1, 2016 to August 31, 2017. The program is designed for senior faculty and intended to enhance the development of future leaders in academic medicine. | | | | Read More | | |
| |
| | | | | Applications are being accepted for the Master of Science in Clinical Research (MSCR) degree program in the Emory Laney Graduate School for classes beginning in August 2016. The MSCR provides didactic and mentored clinical and/or translational research training and is designed for participants who hold a doctorate or equivalent degree (such as physicians and PhD-level scientists) and have demonstrated a commitment to a career in clinical investigation ... | | | | Read More | | |
|
| |
| | | | This FOA invites training grant applications for support of predoctoral and postdoctoral training for research careers in biomedical informatics and data science. Such training helps meet the growing need for investigators trained in biomedical computing, data science, and related information fields as they directly relate to application domains in health and biomedicine, including health care delivery, basic biomedical research, clinical and translational research, public health and similar areas. | | | | Read More | | |
| |
| | | | The purpose is to develop a group of highly trained biomedical scientists to address the Nation's biomedical workforce needs. The IRACDA program provides support for a traditional mentored postdoctoral research experience at a research-intensive institution combined with an opportunity for these fellows to develop critical academic skills, including teaching, through workshops and mentored teaching assignments at a partner institution. | | | | Read More | | |
| |
| | | CPTR is a multidisciplinary, innovative program that provides pre-doctoral or postdoctoral trainees with the expertise and experience to translate fundamental biomedical scientific discoveries into treatments that will benefit human health. Sixteen credits of didactic training focused on translational research in Emory’s Laney Graduate School of Emory University are required to complete the certificate program. Emory faculty and postdocs may ... | | | | Read More | | |
| |
| | | | Allocating Credit: The Overly Nice Advisor | | | | Read More | | |
| |
| | | | | | If you have a research ethics question or are pondering a research ethics dilemma, John Banja, Professor of Rehabilitation Medicine, Emory, and Rebecca Pentz, Professor of Research Ethics in Hematology and Oncology, Winship, are available to confidentially discuss it and offer non-binding advice. Please call or email John at 404-712-4804/jbanja@emory.edu or call or text Becky at 404-831-1758. | | | | Read More | | |
|
| |
| | | | Assay Guidance Manual editors recently added four new chapters to benefit drug discovery scientists worldwide. | | | | Read More | | |
| |
| | | | Effective November 23, 2015, Emory has updated the "Accounting for Service Centers" policy to reflect a change from annual to bi-annual rate calculation submissions. | | | | Read More | | |
| |
| | | | The drive will be held from 7:30 a.m. to 12:30 p.m. for the American Red Cross. To make an appointment, please visit redcrossblood.org and enter sponsor code: emoryjohnscreek or call 1-800-RED-CROSS. The American Red Cross says it is important to eat well and drink plenty of water before and after giving blood.
| | | | Read More | | |
| |
| | | | Presented by Carl Hill, PhD, MPH, Director, Office of Special Populations, National Institute on Aging, NIH and U.S. Department of Health & Human Services | | | | Read More | | |
| |
| | | | The CED Life Science Conference attracts nearly 1,000 participants each year and boasts globally recognized industry leaders as speakers, showcases the most exciting and innovative southeast-based life science companies, and connects these companies to a diverse group of venture capital and corporate investors. | | | | Read More | | |
| |
| | | | Inputs for a decision model often come from the published literature, but may not be in a form suitable for your decision model. This seminar discusses ways of deriving probabilities that are specific to your model's constraints as well as deriving probabilities from published summary statistics. Researchers who are interested in operationalizing their own decision model should participate. | | | | Read More | | |
| |
| | | | The workshops will discuss CER questions related to: management of sickle cell disease, patient-centered palliative care, preventing opioid misuse in pain management, and second-line treatment of Type 2 diabetes. Representatives of a wide range of stakeholder groups, including patients, caregivers, clinicians, industry, insurers, and researchers, will participate. | | | | Read More | | |
| |
| | | | If you are an investor, entrepreneur, or other interested party you should join the University of Florida's 10th annual startup showcase. A Celebration of Innovation is a unique opportunity to see startup companies commercializing the latest life science, medical device, and cutting-edge technologies generated as a result of the more than $700 million in research conducted annually at UF. Those interested in licensing, commercializing, investing or otherwise becoming involved with getting new discoveries to the marketplace should attend. | | | | Read More | | |
| |
| | | | | The K-Club provides an educational forum to assist fellows and faculty. Featuring Dr. Stacy Heilman, Department of Pediatrics, along with a panel of experienced investigators. A light lunch will be provided at noon in Egleston, classrooms 5-7. Flyer | Attend Remotely ... | | | | Read More | | | | |
|
| |
| | | | | | ACTSI and Georgia Bio organize the conference annually to provide critical information on how academia and industry can work together to translate science into discovery and engage communities in clinical research efforts and outcomes. This year's event will explore Georgia's biotechnology climate, venture capital innovation, and feature an expert panel highlighting commercialization training options throughout the state. | | | | Read More | | | | |
|
| |
| For more information on ACTSI, please visit
www.actsi.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
actsi@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
actsi@emory.edu.
Please include the following citation in any publications resulting from direct or indirect ACTSI support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2 TR000455 and TL1 Trainees should also list TL1 TR000456. |
| |
|
![](https://calendar.google.com/calendar/event?action=TEMPLATE&tmeid=<a target="_blank" href="https://calendar.google.com/calendar/event?action=TEMPLATE&tmeid=cmw3bGpqOGUzcGpsN3ZwNDcyZG9ydGxnOTQgYWN0c2lAZW1vcnkuZWR1&tmsrc=actsi%40emory.edu"><img border="0" src="https://www.google.com/calendar/images/ext/gc_button1_en.gif"></a>&tmsrc=actsi%40emory.edu)
![](https://calendar.google.com/calendar/event?action=TEMPLATE&tmeid=<a target="_blank" href="https://calendar.google.com/calendar/event?action=TEMPLATE&tmeid=ODY3OG84bzh1NmYyaGw3bTB2Mm1oc2loNXMgYWN0c2lAZW1vcnkuZWR1&tmsrc=actsi%40emory.edu"><img border="0" src="https://www.google.com/calendar/images/ext/gc_button1_en.gif"></a>&tmsrc=actsi%40emory.edu)
![](https://calendar.google.com/calendar/event?action=TEMPLATE&tmeid=<a target="_blank" href="https://calendar.google.com/calendar/event?action=TEMPLATE&tmeid=YmxwODN1c2tscG81bGZmanJyMGNubGJyMjAgYWN0c2lAZW1vcnkuZWR1&tmsrc=actsi%40emory.edu"><img border="0" src="https://www.google.com/calendar/images/ext/gc_button1_en.gif"></a>&tmsrc=actsi%40emory.edu)
